Drug/Dose | Midazolam Discrimination | Rate % Control ± S.E.M. | ||
---|---|---|---|---|
ED50 | 95% CL | Before Midazolam | After Midazolam | |
mg/kg | ||||
Control | 0.15 | 0.08–0.23 | 102 ± 6 | 97 ± 4 |
+ Buspirone | ||||
0.1 mg/kg | 0.13 | 0.03–0.33 | 96 ± 16 | 30 ± 15 |
0.32 mg/kg | 0.09 | 0.01–0.22 | 102 ± 15 | 45 ± 36 |
1.0 mg/kg | N.S. | N.S. | 36 ± 31 | N.S. |
+ GHB | ||||
100.0 mg/kg | 0.22 | 0.05–0.51 | 87 ± 11 | 108 ± 12 |
320.0 mg/kg | 0.22 | 0.05–0.49 | 91 ± 5 | 87 ± 27 |
560.0 mg/kg | 0.033-a | 0.01–0.07 | 105 ± 9 | 71 ± 12 |
+ Ketamine | ||||
1.0 mg/kg | 0.12 | 0.10–0.13 | 109 ± 8 | 86 ± 25 |
3.2 mg/kg | N.S. | N.S. | 0 | N.S. |
+ Diphenhydramine | ||||
3.2 mg/kg | 0.14 | 0.06–0.25 | 145 ± 21 | 134 ± 19 |
10.0 mg/kg | 0.09 | 0.08–0.10 | 132 ± 3 | 137 ± 25 |
17.8 mg/kg | 0.343-a | 0.20–0.54 | 129 ± 10 | 108 ± 35 |
+ Valproic acid | ||||
320.0 mg/kg | 0.12 | 0.03–0.29 | 116 ± 11 | 110 ± 26 |
560.0 mg/kg | 0.053-a | 0.02–0.09 | 98 ± 17 | 83 ± 35 |
1000.0 mg/kg | 0.033-a | 0.01–0.08 | 96 ± 11 | 84 ± 56 |
Rate of responding includes rate after administration of the pretreatment drug alone (before midazolam) and rate after administration of the pretreatment drug followed by the dose of midazolam resulting in a group average of ≥80% midazolam-lever responding (after midazolam). Data are from at least three monkeys.
N.S., not studied.
↵3-a Significantly different from control (p < 0.05).